CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors
Clinical trial NCT06647329 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06647329
- Sponsor
- Mingzhi Zhang
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-01
- Primary completion
- 2025-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.